Treatment of Bile Acid Diarrhoea With Atorvastatin

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Bile Acid DiarrheaBile Acid Malabsorption
Interventions
DRUG

Atorvastatin

Participants will be orally administering one tablet daily of 40 mg Atorvastatin for two weeks followed by two tablets daily for two weeks (totalling 80 mg daily).

DRUG

Placebo

Placebo tablets are manufactored by the Central Pharmacy of the Capital Region of Denmark and are identical to the IMP except with the active ingredient (atorvastatin) omitted. Participants will be orally administering one tablet daily for two weeks followed by two tablets daily for two weeks.

Trial Locations (1)

2900

RECRUITING

Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup

All Listed Sponsors
collaborator

Fonden til Lægevidenskabens Fremme

OTHER

collaborator

Prosektor Axel Søeborg Ohlsens Mindelegat

OTHER

collaborator

Læge Sofus Carl Emil Friis og Hustru Olga Doris Friis' Legat

OTHER

lead

Asger Lund, MD

OTHER